TGV-inhalonix’s New Drug To Help Patients With Resistant Fungal Lung Infections
The New York drug development company says its Mul-1867 drug candidate shows high potential for treating cystic fibrosis and other ...
The New York drug development company says its Mul-1867 drug candidate shows high potential for treating cystic fibrosis and other ...